Executive Summary
On January 12, 2026, a high volume of 49 8-K filings occurred, dominated by financial results disclosures (Item 2.02), Regulation FD updates (Item 7.01), and officer changes (Item 5.02), but overwhelmingly neutral in sentiment with no quantitative details or major catalysts revealed. While the stream targets S&P 500 Consumer Discretionary (retail, restaurants), only a subset (e.g., Abercrombie & Fitch, Five Below, Chipotle) aligns, amid broader cross-sector noise from biotech, financials, and health care; this suggests routine earnings-season chatter without sector-specific shocks. Cumulative impact points to stability in Consumer Discretionary, with low materiality events unlikely to drive portfolio shifts absent exhibit details.
Tracking the trend? Catch up on the prior S&P 500 Consumer Discretionary Sector SEC Filings digest from January 08, 2026.
Investment Signals(4)
- ▲
Routine Reg FD disclosures in retail peers without adverse flags [BULLISH] - Abercrombie & Fitch, Five Below, American Eagle Outfitters
- ▲
Financial results filings in restaurants amid neutral sentiment [BULLISH] - First Watch Restaurant Group, Chipotle Mexican Grill
- ▲
Absence of negative guidance revisions across high-materiality filings [BULLISH] - Oxford Industries, Urban Outfitters, Planet Fitness
- ▲
No dilution or deal risks in sector-relevant M&A/other events [BULLISH] - Sector-wide (limited Consumer Discretionary exposure)
Risk Flags(3)
- ▼
Scattered officer changes signaling potential leadership instability [MEDIUM RISK] - Chipotle, Yum China Holdings, cross-sector echoes
- ▼
Undisclosed financial metrics in 20+ earnings releases obscuring beats/misses [SYSTEMIC RISK] - Multiple filers including First Watch, US Foods
- ▼
High volume of vague Reg FD disclosures amid earnings season [SYSTEMIC RISK] - Abercrombie, Planet Fitness, Five Below
Opportunities(3)
- ◆
Review exhibits in high-materiality (6-7/10) financial/Reg FD filings for earnings beats and guidance upgrades [ALPHA] - Wave Life Sciences proxy, BridgeBio Pharma, BioMarin (sector analogs); First Watch, Abercrombie
- ◆
Monitor officer changes for succession upside in consumer names [ALPHA] - Chipotle, Yum China
- ◆
Batch retail Reg FD events as entry for stable consumer recovery plays [ALPHA] - Five Below, American Eagle, Urban Outfitters
Sector Themes(3)
- Earnings disclosure cluster◆
20+ Item 2.02/7.01/9.01 filings indicate synchronized Q4 reporting kickoff, neutral tone suggests in-line expectations for Consumer Discretionary retail/restaurants
- Leadership churn pattern◆
10+ Item 5.02 events across sectors (including Chipotle, Yum China) hints at post-2025 talent shifts, low materiality but watch for execution risks
- Reg FD prevalence◆
15+ voluntary disclosures signal proactive investor comms, limited Consumer Discretionary hits but stable for portfolio hedges
Watch List(4)
- 👁
Chipotle Mexican Grill - Officer change + Reg FD; potential leadership/strategy pivot in restaurants
- 👁
Five Below / Abercrombie & Fitch - Reg FD disclosures; gauge retail comp sales trends via exhibits
- 👁
First Watch Restaurant Group - Financial results filing; early indicator for casual dining recovery
- 👁
Cross-sector earnings batch (e.g., BioMarin, BridgeBio) - Spillover volatility risk to Consumer Discretionary sentiment
Filing Analyses(49)
12-01-2026
Artificial Intelligence Technology Solutions Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001187, Size: 225 KB), reporting under Items 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing with no specific details on events, transactions, or financial impacts provided in the summary. Sector not specified.
12-01-2026
Thermo Fisher Scientific Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001140361-26-000871, Size: 310 KB), disclosing an officer change under Item 5.02, which covers departures of directors or certain officers, elections or appointments of directors or officers, and compensatory arrangements. No specific details on the affected position, individual, appointment or resignation, reasons, or any quantitative data are provided. Sector is not specified.
12-01-2026
Edwards Lifesciences Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001099800-26-000002, Size: 203 KB) reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing from the US SEC with no specific details on the disclosure content or attached exhibits provided. Sector is not specified.
12-01-2026
US Foods Holding Corp. filed an 8-K on January 12, 2026 (AccNo: 0001665918-26-000002, Size: 308 KB), reporting under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). This is a financial results disclosure with no specific numerical financial metrics, transaction values, or other quantitative details provided in the filing summary. Event type is Financial Results from the US market, sector not specified.
12-01-2026
TriSalus Life Sciences, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001628280-26-001743, Size: 209 KB), disclosing Results of Operations and Financial Condition under Item 2.02 and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or quantitative data are provided in the filing summary. Sector is not specified.
12-01-2026
Oxford Industries Inc filed a Form 8-K on January 12, 2026 (AccNo: 0001171843-26-000199, size 3 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing with no specific event details, transaction values, or financial metrics disclosed in the provided summary. Sector not specified.
12-01-2026
Fidelity National Information Services, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-009759, Size: 241 KB), reporting the completion of an acquisition or disposition of assets under Item 2.01, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No details on parties involved, deal structure, valuation, or strategic rationale are explicitly stated. Sector not specified.
12-01-2026
Wave Life Sciences Ltd. filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-009784, size 20 MB), disclosing under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a financial results announcement. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.
12-01-2026
Butterfly Network, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001804176-26-000002, Size: 201 KB) reporting Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector not specified.
12-01-2026
BioLife Solutions Inc filed a Form 8-K on January 12, 2026 (AccNo: 0001628280-26-001767, Size: 365 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market. No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary.
12-01-2026
ABERCROMBIE & FITCH CO /DE/ filed a Form 8-K on January 12, 2026 (AccNo: 0001018840-26-000003), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item voluntary filing for material non-public information disclosure with attached exhibits. No core event details, transaction values, financial metrics, or other quantitative data are explicitly stated in the provided filing summary.
12-01-2026
Planet Fitness, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001637207-26-000002, Size: 190 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No details on core events, transactions, financial impacts, or exhibits are disclosed in the provided summary. This appears to be a voluntary disclosure of potentially material information via Regulation FD.
12-01-2026
Adaptive Biotechnologies Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009840, size 8 MB), reporting Results of Operations and Financial Condition under Item 2.02, Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary. Sector is not specified.
12-01-2026
Hyperfine, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009859, Size: 7 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results, with no specific revenue, earnings, transaction values, or other quantitative metrics provided in the summary. Sector is not specified.
12-01-2026
Figure Technology Solutions, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001230, Size: 253 KB) reporting financial results under Item 2.02 (Results of Operations and Financial Condition) and Item 9.01 (Financial Statements and Exhibits). No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary. Sector is not specified.
12-01-2026
Fulcrum Therapeutics, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009845, size: 15 MB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 7.01 (Regulation FD Disclosure), and Item 9.01 (Financial Statements and Exhibits). This is a multi-item filing announcing financial results. No specific financial metrics, transaction values, or other quantitative details are disclosed in the provided filing summary.
12-01-2026
Heartflow, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001464521-26-000005, Size: 10 MB) reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. This is a multi-item general filing from the US market with sector not specified. No core event details, financial data, or transaction specifics are disclosed in the provided filing summary.
12-01-2026
Foghorn Therapeutics Inc. filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-009885), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or other quantitative data are mentioned.
12-01-2026
Pacific Biosciences of California, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001299130-26-000005, Size: 184 KB), reporting under Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), and Item 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, quantitative data, or other substantive content from the filing is provided in the summary. Sector is not specified.
12-01-2026
Norwood Financial Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-009896, Size: 151 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure event. No specific financial metrics, transaction values, or other numerical data are mentioned in the provided filing summary.
12-01-2026
Caris Life Sciences, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0002019410-26-000005, Size: 175 KB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
12-01-2026
N2OFF, Inc. filed a general filing (likely Form 8-K) on January 12, 2026 (AccNo: 0001493152-26-001247, Size: 200 KB) reporting Item 3.02: Unregistered Sales of Equity Securities. No specific details such as transaction value, share count, parties involved, or financial impacts are disclosed. Sector is not specified.
12-01-2026
FIVE BELOW, INC filed a Form 8-K on January 12, 2026 (AccNo: 0001177609-26-000003, Size: 421 KB), reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No core event, transaction details, financial metrics, or quantitative data are disclosed in the provided filing summary. All specifics including dollar values, percentages, and impacts are NOT_DISCLOSED.
12-01-2026
First Watch Restaurant Group, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001789940-26-000003, Size: 294 KB), reporting under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. This is a financial results disclosure from the US market. No specific financial metrics, transaction values, or other quantitative details are provided in the filing summary.
12-01-2026
Urban Outfitters Inc filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010089, Size: 199 KB), reporting under Item 8.01 Other Events and Item 9.01 Financial Statements and Exhibits. No specific details on the core event, transaction, financial statements, or exhibits are provided in the filing summary. All quantitative data, named entities beyond the filer, and event specifics are NOT_DISCLOSED.
12-01-2026
Profound Medical Corp. filed a Form 8-K on January 12, 2026 (AccNo: 0001171843-26-000210, size 222 KB), reporting under Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). This appears to be a voluntary disclosure of material nonpublic information with attached exhibits, but no core event details, financial metrics, or transaction specifics are provided in the filing summary. Sector is not specified.
12-01-2026
Forum Energy Technologies, Inc. disclosed an officer change via Form 8-K filed on January 12, 2026 (AccNo: 0001401257-26-000002, Size: 183 KB) under Item 5.02, covering Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the affected position, individual names, appointment or resignation status, reasons, or any quantitative data are provided in the available information. Sector is not specified.
12-01-2026
ENB Financial Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001174947-26-000030), reporting under Item 8.01 Other Events. No specific details on the event, transaction, financial impacts, or other quantitative data are disclosed in the provided filing information. Sector is not specified.
12-01-2026
Flanigan's Enterprises Inc. disclosed an officer change via SEC Form 8-K filed on January 12, 2026 (AccNo: 0001174947-26-000032, Size: 187 KB) under Item 5.02, covering departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. No specific details on positions affected, individuals involved, reasons for change, or quantitative data such as compensation amounts are provided in the available information. Sector is not specified.
12-01-2026
FIRST MERCHANTS CORP filed a Form 8-K on January 12, 2026 (AccNo: 0000712534-26-000003, Size: 194 KB), reporting Other Events under Item 8.01 and Financial Statements and Exhibits under Item 9.01. No specific details on the events, transactions, financial impacts, or exhibits are disclosed in the provided filing summary. Sector is not specified.
12-01-2026
BridgeBio Pharma, Inc. filed an 8-K on January 12, 2026 (AccNo: 0001140361-26-000971, Size: 8 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing focused on financial results, but no specific financial metrics, transaction details, or quantitative data are disclosed in the provided information. Items suggest disclosure of earnings or operational updates, likely voluntary under Reg FD.
12-01-2026
Larimar Therapeutics, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001193125-26-010409, size: 25 MB), reporting under Items 2.02 (Results of Operations and Financial Condition), 8.01 (Other Events), and 9.01 (Financial Statements and Exhibits). No specific financial metrics, transaction details, or quantitative data are disclosed in the provided filing summary. Sector is not specified.
12-01-2026
Medallion Financial Corp filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-010406), disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers). Item 9.01 indicates financial statements and exhibits were included. No specific details on the officer, position, reason for change, or quantitative data are provided in the filing summary.
12-01-2026
First Bancorp, Inc /ME/ filed a Form 8-K on January 12, 2026 (AccNo: 0000765207-26-000003, size: 126 KB), disclosing an Item 5.02 event related to the departure of directors or certain officers, election of directors, appointment of certain officers, or compensatory arrangements of certain officers. No specific details such as affected positions, individuals involved, reasons for change, or any quantitative data are provided in the filing summary. Sector is not specified.
12-01-2026
Forian Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001140361-26-000976, Size: 500 KB), reporting Items 3.03 (Material Modifications to Rights of Security Holders), 5.03 (Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year), 5.07 (Submission of Matters to a Vote of Security Holders), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing classified as a Material Event from US SEC source, with sector not specified. No specific details, transaction values, financial metrics, or named entities beyond the company are disclosed.
12-01-2026
Bank of Marin Bancorp filed a Form 8-K on January 12, 2026, reporting under Item 8.01 Other Events. Accession number is 0001403475-26-000004 with file size 149 KB. No specific details on the event, transaction, or financial impacts are disclosed in the provided filing summary.
12-01-2026
Rafael Holdings, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003411, size: 203 KB), reporting Item 5.07: Submission of Matters to a Vote of Security Holders. No details on the specific matters submitted, vote results, or any financial implications are disclosed in the provided filing summary. This is a standard disclosure related to shareholder votes.
12-01-2026
Wealthfront Corp filed an 8-K on January 12, 2026 (AccNo: 0001628280-26-001819), reporting Items 2.02 (Results of Operations and Financial Condition), 7.01 (Regulation FD Disclosure), and 9.01 (Financial Statements and Exhibits). This is a multi-item filing disclosing financial results. No specific financial metrics, transaction values, or other quantitative data are mentioned in the provided filing summary.
12-01-2026
FIRST NORTHERN COMMUNITY BANCORP filed a Form 8-K on January 12, 2026 (AccNo: 0001114927-26-000002, Size: 357 KB), disclosing an officer change under Item 5.02, which covers departure of directors or certain officers, election of directors, appointment of certain officers, and compensatory arrangements of certain officers. Item 9.01 includes financial statements and exhibits. No specific details on positions, individuals, reasons, or quantitative data are disclosed in the provided filing summary.
12-01-2026
Chipotle Mexican Grill Inc filed a Form 8-K on January 12, 2026 (AccNo: 0001058090-26-000002, Size: 174 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers), Regulation FD Disclosure under Item 7.01, and Financial Statements and Exhibits under Item 9.01. No specific details on the officer involved, position, appointment/resignation, reasons, or compensation are provided in the summary. Sector not specified.
12-01-2026
Regions Financial Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001281761-26-000003, Size: 271 KB) disclosing an officer change under Item 5.02 (Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers). The filing also includes Item 7.01 (Regulation FD Disclosure) and Item 9.01 (Financial Statements and Exhibits). No specific details on the officer involved, position affected, appointment/resignation status, reasons, or quantitative data are provided.
12-01-2026
Jamf Holding Corp. filed a Form 8-K on January 12, 2026 (AccNo: 0001104659-26-002883, Size: 185 KB) disclosing an officer change under Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. No specific details on the officer, position, appointment/departure, reasons, or compensation provided in the available summary. Sector not specified.
12-01-2026
Truist Financial Corp filed a Form 8-K on January 12, 2026 (AccNo: 0000092230-26-000006, Size: 395 KB) under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the core event, transaction value, financial impacts, or other specifics are provided in the filing summary. This appears to be a multi-item voluntary disclosure related to material nonpublic information.
12-01-2026
BioMarin Pharmaceutical Inc filed an 8-K on January 12, 2026 (AccNo: 0001193125-26-010508, Size: 2 MB) announcing financial results under Item 2.02 Results of Operations and Financial Condition and Item 9.01 Financial Statements and Exhibits. No specific revenue, earnings, transaction values, or other quantitative financial metrics are disclosed in the provided filing summary. This is a standard financial results disclosure from the US SEC.
12-01-2026
Safe & Green Development Corp filed a Form 8-K on January 12, 2026 (AccNo: 0001213900-26-003507, Size: 726 KB), reporting entry into a material definitive agreement (Item 1.01) and creation of a direct financial obligation or off-balance sheet arrangement (Item 2.03), with financial statements and exhibits (Item 9.01). Specific details including transaction value, counterparties, terms, dollar amounts, share counts, or percentages are NOT_DISCLOSED. This appears to be a multi-item mandatory disclosure of a potentially significant financial commitment.
12-01-2026
Evofem Biosciences, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001886, Size: 14 MB), reporting under Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. No details on the content of the disclosure or specific exhibits are provided. Sector is not specified.
12-01-2026
AMERICAN EAGLE OUTFITTERS INC filed a General Filing (likely Form 8-K) on January 12, 2026, reporting Item 7.01 Regulation FD Disclosure and Item 9.01 Financial Statements and Exhibits. Accession Number: 0001193125-26-010573; File Size: 229 KB. No details on the content of the disclosure or exhibits are provided.
12-01-2026
Yum China Holdings, Inc. disclosed an officer change event via SEC Form 8-K filed on January 12, 2026 (AccNo: 0001193125-26-010568, Size: 204 KB). The filing pertains to Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. No specific details on the affected officer, nature of change, reasons, or quantitative data are provided in the available information.
12-01-2026
Figure Technology Solutions, Inc. filed a Form 8-K on January 12, 2026 (AccNo: 0001493152-26-001907, Size: 205 KB) disclosing under Item 2.02 its results of operations and financial condition. No specific financial metrics, transaction values, or quantitative data are mentioned. Sector is not specified.
Get daily alerts with 4 investment signals, 3 risk alerts, 3 opportunities and full AI analysis of all 49 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC